Premium
Prolactin‐Secreting pituitary tumors
Author(s) -
Antunes J. Lobo,
Housepian Edgar M.,
Frantz Andrew G.,
Holub Donald A.,
Hui Robert M.,
Carmel Peter W.,
Quest Donald O.
Publication year - 1977
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410020210
Subject(s) - prolactin , galactorrhea , medicine , pituitary tumors , prolactinoma , prolactin cell , pituitary adenoma , adenoma , radiation therapy , secretion , endocrinology , pituitary neoplasm , pituitary gland , hormone
Prolactin secretion was evaluated in 69 patients with pituitary tumors. Among the 47 who were seen prior to treatment, hyperprolactinemia was present in 37 (79%). Excluding patients with galactorrhea, hyperprolactinemia was present in 19 (70%) of those seen before treatment. There was little correlation between tumor size and level of serum prolactin. Both transspheoidal surgery and radiotherapy greatly reduced the hyperprolactinemia, but a more rapid decrease was achieved with microsurgical removal of the secreting adenoma.